EFXEQUIFAX INC

NYSE equifax.com


$ 214.52 $ -2.99 (-1.37 %)    

Friday, 19-Apr-2024 15:11:54 EDT
QQQ $ 414.71 $ -8.48 (-2 %)
DIA $ 379.20 $ 0.72 (0.19 %)
SPY $ 495.15 $ -4.28 (-0.86 %)
TLT $ 89.08 $ -0.28 (-0.31 %)
GLD $ 221.71 $ 1.66 (0.75 %)
$ 217.51
$ 217.21
$ 201.56 x 100
$ 0.00 x 0
$ 213.17 - $ 218.14
$ 159.41 - $ 275.10
3,635,752
na
26.95B
$ 1.31
$ 49.42
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-22-2024 12-31-2023 10-K
2 10-23-2023 09-30-2023 10-Q
3 07-25-2023 06-30-2023 10-Q
4 04-20-2023 03-31-2023 10-Q
5 02-23-2023 12-31-2022 10-K
6 10-20-2022 09-30-2022 10-Q
7 07-21-2022 06-30-2022 10-Q
8 04-21-2022 03-31-2022 10-Q
9 02-24-2022 12-31-2021 10-K
10 10-21-2021 09-30-2021 10-Q
11 07-22-2021 06-30-2021 10-Q
12 04-22-2021 03-31-2021 10-Q
13 02-25-2021 12-31-2020 10-K
14 10-22-2020 09-30-2020 10-Q
15 07-23-2020 06-30-2020 10-Q
16 04-21-2020 03-31-2020 10-Q
17 02-20-2020 12-31-2019 10-K
18 10-25-2019 09-30-2019 10-Q
19 07-25-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 02-21-2019 12-31-2018 10-K
22 10-25-2018 09-30-2018 10-Q
23 07-26-2018 06-30-2018 10-Q
24 04-26-2018 03-31-2018 10-Q
25 03-01-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 07-27-2017 06-30-2017 10-Q
28 04-27-2017 03-31-2017 10-Q
29 02-22-2017 12-31-2016 10-K
30 10-27-2016 09-30-2016 10-Q
31 07-28-2016 06-30-2016 10-Q
32 04-29-2016 03-31-2016 10-Q
33 02-24-2016 12-31-2015 10-K
34 10-22-2015 09-30-2015 10-Q
35 07-23-2015 06-30-2015 10-Q
36 04-23-2015 03-31-2015 10-Q
37 02-25-2015 12-31-2014 10-K
38 10-23-2014 09-30-2014 10-Q
39 07-24-2014 06-30-2014 10-Q
40 04-24-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 b-of-a-securities-maintains-buy-on-equifax-lowers-price-target-to-255

B of A Securities analyst Heather Balsky maintains Equifax (NYSE:EFX) with a Buy and lowers the price target from $300 to $255.

 oppenheimer-maintains-outperform-on-equifax-lowers-price-target-to-272

Oppenheimer analyst Owen Lau maintains Equifax (NYSE:EFX) with a Outperform and lowers the price target from $291 to $272.

 goldman-sachs-maintains-neutral-on-equifax-lowers-price-target-to-241

Goldman Sachs analyst George Tong maintains Equifax (NYSE:EFX) with a Neutral and lowers the price target from $276 to $241.

 jp-morgan-maintains-overweight-on-equifax-lowers-price-target-to-273

JP Morgan analyst Andrew Steinerman maintains Equifax (NYSE:EFX) with a Overweight and lowers the price target from $290 to ...

 baird-maintains-outperform-on-equifax-lowers-price-target-to-260

Baird analyst Jeffrey Meuler maintains Equifax (NYSE:EFX) with a Outperform and lowers the price target from $275 to $260.

 needham-reiterates-buy-on-equifax-maintains-305-price-target

Needham analyst Kyle Peterson reiterates Equifax (NYSE:EFX) with a Buy and maintains $305 price target.

 equifax-reports-weak-sales-joins-synovus-financial-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session

U.S. stock futures were higher this morning, with the Dow futures gaining over 50 points on Thursday.

 equifax-q1-sales-1389b-miss-1400b-estimate

Equifax (NYSE:EFX) reported quarterly sales of $1.389 billion which missed the analyst consensus estimate of $1.400 billion by ...

 earnings-scheduled-for-april-17-2024

Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is projected to report quarterly earnings at $3.43 per share ...

 oppenheimer-maintains-outperform-on-equifax-raises-price-target-to-291

Oppenheimer analyst Owen Lau maintains Equifax (NYSE:EFX) with a Outperform and raises the price target from $273 to $291.

 worth-ai-and-equifax-enter-strategic-relationship-to-help-improve-underwriting-and-risk-management-for-small-businesses

AI-powered risk management, coupled with access to unique data, accelerates processing time and increases business credit appro...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION